BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 31176360)

  • 1. Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma.
    Yang J; Zhou C; Wang Y; Fan X; Jia R
    BMC Ophthalmol; 2019 Jun; 19(1):125. PubMed ID: 31176360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Outcomes of Eye-Sparing Surgery for Adenoid Cystic Carcinoma of Lacrimal Gland.
    Han J; Kim YD; Woo KI; Sobti D
    Ophthalmic Plast Reconstr Surg; 2018; 34(1):74-78. PubMed ID: 28221296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival outcomes of eye-sparing surgery for adenoid cystic carcinoma of lacrimal gland.
    Hung JY; Wei YH; Huang CH; Chen LW; Fuh CS; Liao SL
    Jpn J Ophthalmol; 2019 Jul; 63(4):344-351. PubMed ID: 31134459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Joint Committee on Cancer classification predicts outcome of patients with lacrimal gland adenoid cystic carcinoma.
    Ahmad SM; Esmaeli B; Williams M; Nguyen J; Fay A; Woog J; Selvadurai D; Rootman J; Weis E; Selva D; McNab A; DeAngelis D; Calle A; Lopez A
    Ophthalmology; 2009 Jun; 116(6):1210-5. PubMed ID: 19395039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orbitocranial approach for treatment of adenoid cystic carcinoma of the lacrimal gland.
    Wilson KF; Ward PD; Spector ME; Marentette LJ
    Ann Otol Rhinol Laryngol; 2011 Jun; 120(6):397-400. PubMed ID: 21774448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland.
    Esmaeli B; Ahmadi MA; Youssef A; Diba R; Amato M; Myers JN; Kies M; El-Naggar A
    Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):22-6. PubMed ID: 14752305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment of lacrimal gland carcinoma.
    Woo KI; Kim YD; Sa HS; Esmaeli B
    Curr Opin Ophthalmol; 2016 Sep; 27(5):449-56. PubMed ID: 27273588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for local recurrence and survival and impact of local treatments on survival in lacrimal gland carcinoma.
    Ford JR; Rubin ML; Frank SJ; Ning J; Debnam JM; Bell D; El-Naggar A; Ferrarotto R; Esmaeli B
    Br J Ophthalmol; 2021 Jun; 105(6):768-774. PubMed ID: 32680839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Staged Procedure in the Treatment of Primary Lacrimal Sac Epithelial Malignancy: A Retrospective Cases Analysis.
    Zhang R; Qian J; Meng F; Yuan Y; Bai M; Bi Y; Xu B; Yuan Y; Hong R
    Ophthalmic Plast Reconstr Surg; 2019; 35(2):187-192. PubMed ID: 30204637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoid cystic carcinoma of the lacrimal gland in a 14-year-old male.
    Falcone MM; Tran KD; Tavakoli M; Ortiz DF; Barredo JC; Lee WW
    Orbit; 2017 Dec; 36(6):448-451. PubMed ID: 28738175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eye-sparing multidisciplinary approach for the management of lacrimal gland carcinoma.
    Esmaeli B; Yin VT; Hanna EY; Kies MS; William WN; Bell D; Frank SJ
    Head Neck; 2016 Aug; 38(8):1258-62. PubMed ID: 27027275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Multimodal Treatment Improve Eye and Life Salvage in Adenoid Cystic Carcinoma of the Lacrimal Gland?
    Manjandavida FP; Honavar SG; Murthy R; Das S; Vemuganti GK; Mulay K; Reddy VAP
    Ophthalmic Plast Reconstr Surg; 2022 Jul-Aug 01; 38(4):348-354. PubMed ID: 34873122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
    Tse DT
    Trans Am Ophthalmol Soc; 2005; 103():337-67. PubMed ID: 17057810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of post-surgical residual tumor burden and radiation therapy in treating patients with lacrimal adenoid cystic carcinoma.
    Noh JM; Lee E; Ahn YC; Oh D; Kim YD; Woo KI; Ko YH; Kim S
    Oncotarget; 2016 Sep; 7(37):60639-60646. PubMed ID: 27372060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor (VEGF) and hypoxia inducible factor-1 alpha (HIF-1ɑ) in lacrimal gland Adenoid cystic carcinoma: Correlation with clinical outcome.
    Anjum S; Sen S; Chosdol K; Bakhshi S; Kashyap S; Pushker N; Bajaj MS; Meel R; Sharma MC
    Ann Diagn Pathol; 2022 Feb; 56():151846. PubMed ID: 34749048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cranio-orbital Resection Does Not Appear to Improve Survival of Patients With Lacrimal Gland Carcinoma.
    Rose GE; Gore SK; Plowman NP
    Ophthalmic Plast Reconstr Surg; 2019; 35(1):77-84. PubMed ID: 30130333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoid Cystic Carcinoma from the salivary and lacrimal glands and the breast: Different clinical outcomes to the same tumor.
    Emerick C; Mariano FV; Vargas PA; Nör JE; Squarize CH; Castilho RM
    Crit Rev Oncol Hematol; 2022 Nov; 179():103792. PubMed ID: 35973662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of locally advanced adenoid cystic carcinoma of the lacrimal gland.
    Esmaeli B; Golio D; Kies M; DeMonte F
    Ophthalmic Plast Reconstr Surg; 2006; 22(5):366-70. PubMed ID: 16985421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy.
    Tse DT; Benedetto PW; Tse BC; Feuer WJ
    Am J Ophthalmol; 2022 Aug; 240():239-251. PubMed ID: 35381201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: "Does Multimodal Treatment Improve Eye and Life Salvage in Adenoid Cystic Carcinoma of the Lacrimal Gland?".
    Rose GE
    Ophthalmic Plast Reconstr Surg; 2022 Jul-Aug 01; 38(4):406. PubMed ID: 35797665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.